comprehensive -WSS

comprehensive

author：focus 2025-09-29 16:46:03 - browse：9

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Readout Newsletter: What happened with Sarepta's Duchenne data

WSS

When is a doctor not a doctor? Try when patients address women doctors

When is a doctor not a doctor? Try when patients address women doctors

Traditional Chinese medicine benefits explored in new JAMA study

The FDA weighs the risks of candy

Emergency medicine has repudiated 'excited delirium.' Now what?

A new study asks: Are we harming blood donors by taking blood?

explore

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

Medicare details structure of new drug price negotiation program

Why is France rioting? What to know about the fatal police shooting of Nahel M

23andMe had bad news about my health. I wish a person had delivered it

4th of July breaks record for highest global temperature ever measured

At least 13 dead in Texas as scorching temps continue

Brain 'hot spot' may explain why African Americans feel greater pain

Walensky prepares to leave CDC — and Congress — behind

Why Sanofi got shellacked over its spinoff

Cancer drug shortages should be causing more outrage

Can food be medicine? And other questions about a new push

knowledge

Physician subsidies by hospitals soar in wake of No Surprises Act

Cassava reveals details — and problems — with Alzheimer's study

Cassava reveals details — and problems — with Alzheimer's study

Biden's order seeks to regulate AI risk without stifling innovation

Doctor appointment wait times are getting worse

Hospitals warn Medicare's drug payment fix is ‘unlawful’

explore

knowledge

focus

focus